Qian X Y, You Z X, Cao Q W, Zou B B, Xing Y
Department of Gynecology, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
Zhonghua Fu Chan Ke Za Zhi. 2018 Sep 25;53(9):613-619. doi: 10.3760/cma.j.issn.0529-567x.2018.09.006.
To observe the missed diagnosis of invasive carcinoma under the microscope (ICUM) in high grade squamous intraepithelial neoplasia (HSIL) , and analyze associated factors influencing missed ICUM. A retrospective study was performed on patients diagnosed with HSIL by colposcopy-guided biopsy and treated with loop electrosurgical excision procedure (LEEP) at the First Affiliated Hospital of Nanjing Medical University, from December 2014 to December 2016. They were non-pregnant, ≤50 years old and the cervical volume without obvious enlargement and exogenous surface without and ulcerative lesions. A total of 283 cases with early cervical cytology results, never received cervical traumatic treatment or cervical biopsy in another hospital before, and their colposcopic images were clear enough to reevaluate. The ultimate pathological diagnosis was based on the higher-level pathological diagnosis between the results of cervical biopsy and LEEP to evaluate ICUM missed in HSIL and the risk factors. (1) Among the 283 cases with HSIL diagnosed by colposcopy-directed biopsy, 44 cases (15.5%, 44/283) were missed diagnosis of ICUM, which consisted of 29 cases Ⅰ a1, 4 cases Ⅰ a2 and 11 cases Ⅰ b1 in the ultimate pathology. (2) Analysis of associated factors for missed ICUM: univariate analysis showed that, as the age increased, the risk of missed ICUM also increased (the rates of missed diagnosis for <30, 30-39, 40-50 years were 7.7%, 11.5%, 22.0%, respectively; χ(2)=6.254, =0.012 by trend test) . The more the number of high-grade features, the higher risks (the rates of missed diagnosis for 1, 2, 3, 4 high-grade features were 10.2%, 17.6%, 23.8%, 30.8%, respectively; χ(2)=7.686, =0.006 by trend test) . The locations of HSIL were only endocervical, only ectocervical and mixed, the risk increased by this sequence (2.8%, 5.1%, 28.7%; χ(2)=26.193, <0.01 by trend test) . The rate of missed diagnosis for not completely visible squamocolumnar junction (SCJ) was higher than that of the completely visible one (22.3% vs 2.1%; χ(2)=19.680, <0.01) . The rate of missed diagnosis was higher for existing atypical vessels than those without (60.7% vs 10.6%; χ(2)=48.279, <0.01) . The rate of missed diagnosis for visible lesion size ≥40 mm(2) was higher than that of <40 mm(2) (27.3% vs 4.2%; χ(2)=28.921, <0.01) . The rate of missed diagnosis for the proportion of visible lesion size in ectocervical size ≥0.75 was higher than that of <0.75 (83.3% vs 14.1%; <0.01) . The rate of missed diagnosis for the maximum linear length of visible lesion ≥10 mm was higher than that of <10 mm (46.9% vs 9.0%; χ(2)=44.473, <0.01) . But the different severity of cervical cytology before colposcopy was not associated with missed ICUM (>0.05) . Multivariable analysis found that visibility of SCJ, atypical vessels, visible lesion size and maximum linear length of visible lesion were associated with missed diagnosis of ICUM (all <0.05) . The diagnostic value of HSIL by colposcopy is limited. Meanwhile, for the patients who are ≤50 years old with HSIL diagnosed by cervical biopsy, invisibility of SCJ, atypical vessels, visible lesion size and maximum linear length of visible lesion evaluated by colposcopy are the independent risk factors of missed ICUM. Thereby, it is necessary to take active intervention for HSIL with these risk factors.
观察高级别鳞状上皮内瘤变(HSIL)中显微镜下浸润癌漏诊(ICUM)情况,并分析影响ICUM漏诊的相关因素。对2014年12月至2016年12月在南京医科大学第一附属医院经阴道镜引导活检诊断为HSIL并行环形电切术(LEEP)治疗的患者进行回顾性研究。纳入标准为非妊娠、年龄≤50岁、宫颈体积无明显增大、外表面无溃疡病变。共有283例患者宫颈细胞学结果早期明确,此前未在其他医院接受过宫颈创伤性治疗或宫颈活检,且阴道镜图像清晰可重新评估。最终病理诊断以宫颈活检与LEEP结果中更高一级的病理诊断为准,以评估HSIL中ICUM漏诊情况及危险因素。(1)在283例经阴道镜引导活检诊断为HSIL的病例中,44例(15.5%,44/283)存在ICUM漏诊,最终病理包括Ⅰa1期29例、Ⅰa2期4例、Ⅰb1期11例。(2)ICUM漏诊相关因素分析:单因素分析显示,随着年龄增加,ICUM漏诊风险增加(<30岁、30 - 39岁、40 - 50岁漏诊率分别为7.7%、11.5%、22.0%;趋势检验χ(2)=6.254,P = 0.012)。高级别特征数量越多,风险越高(1个、2个、3个、4个高级别特征漏诊率分别为10.2%、17.6%、23.8%、30.8%;趋势检验χ(2)=7.686,P = 0.006)。HSIL部位仅在内宫颈、仅在外宫颈及混合性,风险依次增加(2.8%、5.1%、28.7%;趋势检验χ(2)=26.193,P <0.01)。鳞柱交界(SCJ)未完全可见时漏诊率高于完全可见时(22.3%比2.1%;χ(2)=19.680,P <0.01)。存在非典型血管时漏诊率高于无此情况(60.7%比10.6%;χ(2)=48.279,P <0.01)。可见病变大小≥40 mm²时漏诊率高于<40 mm²时(27.3%比4.2%;χ(2)=28.921,P <0.01)。外宫颈可见病变大小占比≥0.75时漏诊率高于<0.75时(83.3%比14.1%;P <0.01)。可见病变最大直线长度≥10 mm时漏诊率高于<10 mm时(46.9%比9.0%;χ(2)=44.473,P <0.01)。但阴道镜检查前宫颈细胞学不同严重程度与ICUM漏诊无关(P>0.05)。多因素分析发现,SCJ可见性、非典型血管、可见病变大小及可见病变最大直线长度与ICUM漏诊相关(均P <0.05)。阴道镜对HSIL的诊断价值有限。同时,对于≤50岁经宫颈活检诊断为HSIL的患者,阴道镜评估的SCJ不可见、非典型血管、可见病变大小及可见病变最大直线长度是ICUM漏诊的独立危险因素。因此,对于存在这些危险因素的HSIL有必要采取积极干预措施。